ERBC will participate to this congress and is is delighted to be a sponsor of this main event for all those interested in the challenges and progress of pathology.
Do not miss the opportunity to follow the presentation from Raafat FARES, associate scientific director, ERBC France, on "Integrative cardiovascular pharmacology model combined to histopathology: novel approach for sudden risk assessment" based on years of experience and publications from Pascal Champeroux and team at ERBC.
As a sponsor, ERBC will participate to SFTP annual meeting.
Webinar organized by ERBC: Small size but big potential, the NHP marmoset in toxicology studies for Biologics and vaccines
The European Research Biology Center is delighted to invite you to its new webinar of a series on Toxicology Studies on May 6, 2021, 11:00 CEST
The Common marmoset (Callithrix jacchus) is a nonhuman primate (NHP) species that is currently highly used in biomedical research.
Webinar organized by ERBC: QT prolongation in drug development, let's have a look beyond the “Best Practice Considerations for the in-vivo QT Studies”
The European Research Biology Center is delighted to invite you to its new webinar of a series on Cardiovascular Safety Assessment on February 25, 2021, 11:00 CET
The Q&A process of the ICHS7B/E14 guidelines points out the requirement for best practices in preclinical safety assessment of drug induced QT prolongation risk.
This step is a real improvement towards a reliable translation from the preclinic to the clinic.
Innovative Solution Providers’ workshop: How do we keep you in the race of Covid-19? Watch the replay
ERBC (European Research Biology Center) and our partners Oncodesign, CYNBIOSE and PharmaLex a.r.c., presented a Digital Workshop “How do we keep you in the race of COVID19 ?“ during BioFIT 2020.
The Italian Society of Environmental Mutagenesis and Genomics (SIMAG) is launching three webinars to improve communication and discussion in this period of travel restrictions. In this first series, three new members of the Society will present themselves.
In parallel, recent research advances of three laboratories of SIMAG members will be communicated by a young component of the team.
Webinar organized by ERBC: The autonomic nervous system: the dark side of cardiovascular safety assessment
The European Research Biology Center is delighted to invite you to its first webinar of a series on Cardiovascular Safety Assessment on October 8, 2020, 11:00 CEST
Despite significant efforts during the two last decades, cardiovascular side effects remain a major root cause of late attrition during drug development. QT prolongation is far to be the only issue.